Prospective, open-label, randomized, phase III study of two...

Annals of Oncology 2013 / 04 Vol. 24; Iss. 4

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Bamias, A., Dafni, U., Karadimou, A., Timotheadou, E., Aravantinos, G., Psyrri, A., Xanthakis, I., Tsiatas, M., Koutoulidis, V., Constantinidis, C., Hatzimouratidis, C., Samantas, E., Visvikis, A., Ch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mds583
Date:
April, 2013
File:
PDF, 152 KB
english, 2013
Conversion to is in progress
Conversion to is failed